Microenvironmental regulation of tumor progression and metastasis

Daniela F Quail1, Johanna A Joyce

  • 1Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

Nature Medicine
|November 9, 2013
PubMed

Insights

Stromal cells in the tumor microenvironment (TME) are key to cancer growth but can be therapeutically reprogrammed. Re-educating these stable stromal cells offers a promising strategy to combat cancer progression and metastasis.

Area of Science:

  • Oncology
  • Cancer Biology
  • Tumor Microenvironment Research

Background:

  • Cancers rely on complex tissue environments for growth, invasion, and metastasis.
  • Stromal cells within the tumor microenvironment (TME) are genetically stable, unlike tumor cells.
  • Targeting the TME is challenging due to its dual role in promoting or hindering tumorigenesis.

Purpose of the Study:

  • To discuss the paradoxical roles of the TME in cancer progression and metastasis.
  • To explore therapeutic strategies focused on re-educating stromal cells.
  • To highlight the potential of stromal cell re-education for cancer treatment.

Main Methods:

  • Review of existing literature on TME composition and function.
  • Analysis of studies investigating stromal cell-tumor cell interactions.
  • Discussion of emerging therapeutic approaches targeting stromal cells.

Main Results:

  • The TME exhibits diverse capacities, influencing tumorigenesis both positively and negatively.
  • Stromal cells can be "re-educated" to exert anti-tumorigenic effects.
  • Targeted ablation of stromal cells may be less effective than reprogramming them.

Conclusions:

  • Reprogramming stromal cells within the TME is a viable therapeutic strategy.
  • Understanding the TME's complex roles is crucial for effective cancer treatment.
  • Future research should focus on developing therapies to re-educate stromal cells for anti-cancer effects.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

2.7K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Tumor Progression02:07

Tumor Progression

3.2K